(Q28204517)
Statements
Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription (English)
Neckers LM
Bonvini P
An WG
Rosolen A
Nguyen P
Garcia de Herreros A
Identifiers
2 references